Accurate,
efficient &
patient-friendly


Non-invasive, painless and immediate liver diagnosis
with quantitative results delivered in real time.

 

Proven liver
fat & stiffness
assessment tools


VCTE™and CAP™ technology documented in over
2,500 peer-reviewed publications worldwide.

 

With over
4,500 systems
worldwide


Echosens has helped support the care
of millions of patients.

WELCOME TO ECHOSENS NORTH AMERICA. WE SPECIALIZE IN NON-INVASIVE, COST-EFFECTIVE TOOLS FOR ASSESSING LIVER HEALTH WITH OUR FIBROSCAN® FAMILY OF PRODUCTS.

Our FibroScan family of products

FibroScan is a pain-free, non-invasive examination of the liver, providing physicians with both liver stiffness and liver fat scores in a single 10-minute procedure. Our FibroScan family of products all come equipped to offer you the same capabilities and examination experience, allowing you the flexibility to choose the size and portability options that suit your needs best.

FibroScan
Unprecedented Mobility for Liver Assessment Efficiency

The FibroScan mini+ is our most portable system, weighing in just over 10lbs, our mini+ is the smallest addition to the FibroScan family of products for access to those who need it most.

Learn more
logo fibroscan 530 compact
Innovation in Liver Disease Management

With its optional roll stand, big 15” touchscreen display, durable yet ergonomic design, the FibroScan Compact is a perfect liver assessment solution for any point-of-care setting.

Learn more

FDA Cleared

FibroScan is the first and only point of care device specifically developed and FDA-Cleared as an aid to the diagnosis and monitoring of adult patients with liver disease. The Shear wave speed stiffness generated by the FibroScan examination may be used as an aid to clinical management of pediatric patients with liver disease.

Learn more about FDA clearance
Dr Nezam Afdhal, Harvard Medical School

Deployed at Beth Israel

"FibroScan is the most effective and best screening test for the diagnosis of chronic liver disease"

Nezam Afdhal, MD
Beth Israel Deaconess Medical Center
See how FibroScan is helping BIDMC

Current media

November 19, 2020 in All, Blog

Comprehensive Economical Analysis Shows Screening Diabetic Patients for NAFLD is Cost Effective in the United States

The prevalence of non-alcoholic fatty liver disease (NAFLD) has reached epidemic levels. The most common liver disease, with a worldwide prevalence of 25%, NAFLD and its subtype, nonalcoholic steatohepatitis (NASH),…
Read More
November 17, 2020 in All, Press Releases

Echosens Presents Research at 2020 AASLD Liver Meeting

November 13, 2020 08:03 AM Eastern Standard Time Documentation for Payers on Cost Effectiveness of FibroScan Screening for Detecting, Monitoring Fatty Liver Disease WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering…
Read More
November 17, 2020 in All, Press Releases

ChronWell, ModifyHealth and Echosens North America Partner to Create LIVErHEALTHY Program for Managing Liver Disease

Partnership will provide better outcomes for Medicare patients managing chronic liver diseases FORT LAUDERDALE, FLA. (PRWEB) NOVEMBER 12, 2020 ChronWell, a digital health and technology-enabled remote care management company, today announced its…
Read More

Contact a representative

In North America there are over 1200+ FibroScan systems in operation & we’re growing!

Speak to a Representative